Bernstein cuts Maplebear to Market Perform and lifts target to $65
Bernstein moved Maplebear down to Market Perform and raised its price target from $60 to $65, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Bernstein analysts lowered their rating on Maplebear shares to Market Perform from Outperform, while at the same time raising the price target from $60 to $65, an increase of 8.3%. The information was published by TradingView.
Based on the October 29 close of $57.11, the new target implies a gain of about 13.8%. The update comes from a single analyst and concerns one company.
why it matters
Several other revisions on Maplebear have appeared over the past 30 days. Citizens, Barclays, Cantor Fitzgerald and Needham also cut their ratings on October 30, while Wells Fargo kept its rating and a $56 target on October 5. Price targets in the latest five notes range from $56 to $65. The string of downgrades signals a more cautious stance among analysts, even though the targets remain close to the current share price.
tags
instruments
sources
- Bernstein downgrades Maplebear to Market Perform from Outperform, raises price target to $65 from $60 — TradingView, 30 October 2026 at 18:01 UTC
- Bernstein downgrades Alnylam Pharmaceuticals to Market Perform from Outperform, lowers price target to $199 — TradingView, 30 October 2026 at 18:03 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗